If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
72.50    -0.50 (-0.68%)
Bid:
72.00
Ask:
73.00
Spread: 1.00 (1.389%)
Market Cap: £339.70m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

EXECUTIVE CHANGES: Avacta names CMO, Mission Group appoints CEO

Tue, 01st Jul 2025 21:59

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News:

----------

Avacta Group PLC - Wetherby, West Yorkshire-based life sciences company - Appoints David Liebowitz as chief medical officer and Yulii Bogatyrenko as an advisor in business development. Liebowitz will lead the company's clinical strategy and execution as it continues to advance its pipeline of targeted cancer therapies and Bogatyrenko will add additional strength to the group's business development strategy, Avacta says. Liebowitz joins Avacta from Inovio Pharmaceuticals, where he served as senior vice president of early-stage clinical development. "David's deep expertise in oncology, coupled with a successful track record of advancing innovative therapies into the clinic, will be instrumental as we continue to execute on our clinical development strategy," says Avacta Chief Executive Christina Coughlin.

----------

Carr's Group PLC - Carlisle, England-based provider of agriculture products, including livestock supplements - Confirms that, further to its announcement in May, Josh Hoopes has been appointed as chief executive with immediate effect. Hoopes joined Carr's in March 2024 as CEO, Global Agriculture, where he led the transformation of the agriculture business. Prior to joining Carr's Group, Hoopes worked for Associated British Foods PLC for more than 10 years. In May, Carr's said David White was stepping down as CEO on June 20. "I am delighted to welcome Josh to the board and into his new position as CEO. The board has full confidence in his ability to lead the execution of our refined strategy, deliver sustainable profitable growth, and create long-term value for shareholders," says Chair Tim Jones.

----------

Mission Group PLC - Devon, England based owner of a group of digital marketing and communications agencies - Following an external process, Mission Group names John Carey as chief executive officer with effect from September 1. Carey has recently held executive positions at Castrol, BP PLC and Abu Dhabi National Oil Corp for Distribution, where he led the company's initial public offer in 2017. "A highly experienced international leader, he brings a diverse breadth of commercial and business transformation expertise with a strong operations and marketing background," says Chair David Morgan of the appointment.

----------

Huddled Group PLC - Nottingham, England-based investor in e-commerce brands - Says Michael Ashley will become chief executive officer. In addition, Martin Higginson will become executive chair with immediate effect after Robin Miller's decision to step down as non-executive chair.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Related News

LONDON MARKET MIDDAY: FTSE 100 up as UK defence spend plans released
30 Jun 2026

LONDON MARKET MIDDAY: FTSE 100 up as UK defence spend plans released

(Alliance News) - Stock prices in London were higher at midday on Tuesday and had strengthened from earlier in the day, as defence stocks were buoyed ...

WINNERS & LOSERS: Defence Holdings jumps; ADM Energy delays results
30 Jun 2026

WINNERS & LOSERS: Defence Holdings jumps; ADM Energy delays results

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.

EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities
25 Jun 2026

EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

Avacta Group News

EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities
25 Jun 2026

EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

Avacta agrees design of pivotal US cancer therapy trial
25 Jun 2026

Avacta agrees design of pivotal US cancer therapy trial

(Sharecast News) - Avacta said on Thursday it had agreed the design of a pivotal US trial for its lead cancer therapy with the US Food and Drug Admini...

Avacta hails "strong progress" in first half of 2026
22 Jun 2026

Avacta hails "strong progress" in first half of 2026

(Alliance News) - Avacta Group PLC on Monday said it continued its "strong progress" in the first half of 2026.

IN BRIEF: Avacta Group raises GBP9 million for bond repayments
5 Jun 2026

IN BRIEF: Avacta Group raises GBP9 million for bond repayments

Avacta Group PLC - London-based clinical-stage biopharmaceutical company - Raises gross proceeds of approximately GBP9 million from institutional inve...

Avacta to reduce convertible bond debt after £9m placing
5 Jun 2026

Avacta to reduce convertible bond debt after £9m placing

(Sharecast News) - Avacta announced on Friday that it had raised about £9m through an oversubscribed placing with institutional investors and exi...

EARNINGS AND TRADING: Blencowe updates Orom-Cross net present value
29 May 2026

EARNINGS AND TRADING: Blencowe updates Orom-Cross net present value

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported...

Avacta strengthens oncology position in 2025
19 May 2026

Avacta strengthens oncology position in 2025

(Sharecast News) - Avacta Group said on Tuesday that it had strengthened its position as a pure-play oncology biopharmaceutical company during 2025, w...